ZAI LAB (09688) saw its stock price plummet by 5.04% during intraday trading on Monday, as the Hong Kong biomedical sector experienced a widespread decline. The significant drop in ZAI LAB's share price aligns with the overall negative trend observed among its peers in the biomedical industry.

The decline in ZAI LAB's stock was part of a larger sector-wide movement that affected several prominent biomedical companies listed in Hong Kong. Junshi Biosciences led the downturn with an 8% fall, while other major players such as WuXi AppTec, WuXi Biologics, and Tigermed also saw significant drops ranging from 4% to 6%.

This sector-wide sell-off suggests that investors may be reassessing their positions in biomedical stocks, possibly due to broader market concerns or industry-specific factors. As ZAI LAB's 5.04% decline is in line with the losses experienced by its peers, it appears that the company's stock movement is primarily influenced by this larger trend rather than any company-specific news or events.